"Swiss food group Nestle is to buy drugmaker Pfizer's baby food business for $11.85 billion, beating out French rival Danone in the battle for dominance of fast-growing emerging markets. The world's biggest food company had to dig deeper than expected into its ample pockets to win the high-stakes fight for Pfizer Nutrition, which makes 85 percent of its sales in emerging markets and is Nestle's biggest deal to date." —What could go wrong?

I have a friend I'll call Patrick who lives in Tucson, the small southern Arizona town where I spent 14 years of my childhood. A six-four wall of a man, softened in parts by pints and whiskey, Patrick and I have been close since high school, when his family–a big, pasty, Irish affair–moved to town from Phoenix. Once, on a trip to a low-budget Mexican beach community named Rocky Point, Patrick and I conspired to eat our vegan friend's entire supply of peanut butter and jelly while he was in the shower, leaving only his toothbrush in an empty jar of Skippy. While he screamed, "Do you know how hard [...]